Logo Image
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Partners
More
Publications
All PublicationsMHE PublicationFormulary Watch SupplementsFormulary Watch SpotlightsSupplements And Featured Publications
Events
HSE SummitWebinars
CME/CE
Resources
PBMI InnovatorsEmerging LeadersInteractive ToolsSponsored Content
PBM Directory
Commentaries

Subscribe

  • News
  • Watch
  • Conferences
  • Partners
  • Publications
  • Events
  • CME/CE
  • Resources
  • PBM Directory
  • Commentaries
  • Subscribe
  • ADHD
  • Acute Pain
  • Asthma
  • Atrial Fibrillation
  • Autoimmune Diseases
  • Biologics
  • Biosimilars
  • Blood Cancer
  • Breast Cancer
  • Bronchiectasis
  • COVID-19
  • Cardiovascular Diseases
  • Depression
  • Dermatology
  • Digital Health
  • Drug Coverage
  • Duchenne Muscular Dystrophy
  • Eyecare
  • FDA
  • Friedreich Ataxia
  • Gene Therapy
  • Graft Versus Host Disease
  • HIV
  • Health Systems
  • Heart Failure
  • Hemophilia
  • Hidradenitis Suppurativa
  • Hypertrophic Cardiomyopathy (HCM)
  • Infectious Disease
  • Leukemia and Lymphoma
  • Liver Disease
  • Lung Cancer
  • Mental Health
  • Metabolic Dysfunction-Associated Steatohepatitis
  • Multiple Sclerosis
  • NSCLC
  • Neonatal Care
  • Nephrology
  • Obstetrics-Gynecology & Women's Health
  • Oncology
  • Oncology Biomarkers
  • Opioids
  • PTSD
  • Pediatrics
  • Plaque Psoriasis
  • Population Health
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Pulmonary Arterial Hypertension
  • RSV
  • Reproductive Health
  • Respiratory Conditions
  • Safety & Recalls
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep Disorders
  • Solid Tumors
  • Spinal Muscular Atrophy
  • Substance Use Disorder
  • The Improving Patient Access Podcast
  • Type 2 Diabetes
  • Type I Diabetes
  • Type II Inflammation
  • Ulcerative Colitis
  • Uro-Oncology
  • Urothelial Carcinoma
  • Vaccines
  • Women's Health
  • Year in Review- Dermatology
Spotlight -
AMCP Nexus 2026|
State of the Industry survey: Share your 2027 outlook|
HSES 2026
Advertisement

James J. Oh

Advertisement
James J. Oh

James J. Oh is an employment and labor lawyer for Espstein Green Becker in the firm's Chicago office.

Articles by James J. Oh

Don’t Panic. Or Don’t Get Your Hopes Up. The FTC’s Proposed Rule Banning Non-competes May or May Not Go Into Effect

ByJames J. Oh
March 20th 2023

Even if the Federal Trade Commission were to ban noncompetes, legal challenges to block the ban are nearly certain.

Advertisement

Latest Updated Articles

  • Don’t Panic. Or Don’t Get Your Hopes Up. The FTC’s Proposed Rule Banning Non-competes May or May Not Go Into Effect
    Don’t Panic. Or Don’t Get Your Hopes Up. The FTC’s Proposed Rule Banning Non-competes May or May Not Go Into Effect

    March 20th 2023



Advertisement
Advertisement

Trending on Managed Healthcare Executive

1

WHO adds two Bundibugyo vaccines to Ebola trial in the DRC

2

On Medicaid cuts, the Medicare Advantage market, commercial insurance and the future of U.S. health insurance: A conversation with Geisinger's Jeremy Gaskill

3

Cigna’s third-quarter earnings show a drop in income from its pharmacy benefit business

4

Medicare changes are here to stay. 3 ways health plans can support members through them

5

'Bad data in, means bad data out'—pharmacists on the limits of AI in managed care

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Formulary Watch
  • Pharmacy Benefit Management Institute
Managed Healthcare Executive
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us